23 results
8-K
EX-4.1
NRXP
NRX Pharmaceuticals Inc
19 Apr 24
NRx Pharmaceuticals, Inc. Announces Proposed Underwritten Public Offering of Common Stock
5:10pm
10-K
2023 FY
EX-4.9
NRXP
NRX Pharmaceuticals Inc
Annual report
29 Mar 24
5:18pm
10-K
2023 FY
EX-4.8
NRXP
NRX Pharmaceuticals Inc
Annual report
29 Mar 24
5:18pm
8-K
EX-4.1
NRXP
NRX Pharmaceuticals Inc
28 Feb 24
NRx Pharmaceuticals, Inc. Announces Proposed Underwritten Public Offering of Common Stock
5:09pm
8-K
EX-4.1
NRXP
NRX Pharmaceuticals Inc
1 Sep 23
NRx Pharmaceuticals Announces Definitive Purchase Agreement for Preferred Shares at $0.40 per share
4:48pm
8-K/A
EX-4.2
la10nkq3z5xs
7 Jun 23
NRx Pharmaceuticals Announces $6.28 Million Registered Direct Offering
5:18pm
8-K/A
EX-4.1
w8z55
7 Jun 23
NRx Pharmaceuticals Announces $6.28 Million Registered Direct Offering
5:18pm
8-K
EX-4.2
eiqcoz3tn8clntyta6in
6 Jun 23
NRx Pharmaceuticals Announces $6.28 Million Registered Direct Offering
4:27pm
8-K
EX-4.1
s23h 7o0r
6 Jun 23
NRx Pharmaceuticals Announces $6.28 Million Registered Direct Offering
4:27pm
8-K/A
EX-4.1
amcj9kah
14 Mar 23
NRx Pharmaceuticals Announces Close of $2.9 Million Registered Direct Offering
6:45am
8-K
EX-4.1
uwyhp
9 Mar 23
NRx Pharmaceuticals Announces Close of $2.9 Million Registered Direct Offering
8:46am
8-K
EX-4.3
dvd80jiebl6xp4n8
22 Nov 17
Big Rock Partners Acquisition Corp. Announces Pricing of $60 Million Initial Public Offering
12:00am
8-K
EX-4.2
5axtuv35jr helbbf8
22 Nov 17
Big Rock Partners Acquisition Corp. Announces Pricing of $60 Million Initial Public Offering
12:00am
8-K
EX-4.1
h20n6wnfsdf7v8 v7x
22 Nov 17
Big Rock Partners Acquisition Corp. Announces Pricing of $60 Million Initial Public Offering
12:00am
S-1/A
EX-4.4
nmk6o9 rosi
14 Nov 17
IPO registration (amended)
12:00am
S-1/A
EX-4.7
zal412cz2f4rinhq0
14 Nov 17
IPO registration (amended)
12:00am
S-1/A
EX-4.5
znaoauapjhjf6 8dg1r
14 Nov 17
IPO registration (amended)
12:00am
S-1/A
EX-4.1
kqq4j jl7fcp
14 Nov 17
IPO registration (amended)
12:00am